Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis.
about
Perioperative thrombotic complications in liver transplantationDifferential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosisDeep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review.Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays.Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosisHypercoagulability as a contributor to thrombotic complications in the liver transplant recipient.Clinical utility of viscoelastic tests of coagulation in patients with liver disease.Management of portal vein thrombosis in liver cirrhosis.Management of coagulation abnormalities in liver disease.Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.A conceptual and practical approach to haemostasis in paediatric liver disease.Critical Care management of the cirrhotic patient awaiting liver transplant in the Intensive Care Unit.Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics.Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study.Intensive Care Therapy for Patients with Advanced Liver Diseases
P2860
Q26799735-6FF10DAA-D6EB-43DE-B2EC-735FBB955C57Q28539503-D8F99A2B-BCD6-4494-846D-076B95A7661FQ33626817-BC244F8E-BF56-42DC-9E4B-5B7768FD9014Q35154142-E7FF024D-3856-4F13-B727-255F90353113Q36363182-55D6CE5C-43F1-4F31-8440-5264888D24BBQ38089361-32ADEB54-10AF-4693-8017-1FBEC9C07088Q38103574-88E1F71F-5459-43B5-9947-E104E51182D6Q38200854-002B6608-58AC-4573-9B80-F0397C7FC1E1Q38223728-ACD0AD28-2E3E-4FA1-8DF3-7A54353F79BAQ38232769-6FFDC3C1-1518-4AF4-BBCB-5D70FF0DD438Q38788396-5DF2B7CF-7EED-4382-A5EB-2C5998FB1D46Q39422269-AF673652-B569-4F32-AB93-FA297ED6292FQ45394131-DB6A6A25-67B5-4197-8BCB-C2B13F2B0AE3Q52445950-06CB6A6B-1603-46A3-ACDB-02CEB9C95FDCQ53513180-2F7FB7EB-B6BB-46E5-BF99-B6A59006F59DQ57824678-1E29E742-C449-4517-A48D-D2AAC56CF176
P2860
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Increased anticoagulant respon ...... ients with advanced cirrhosis.
@en
Increased anticoagulant respon ...... ients with advanced cirrhosis.
@nl
type
label
Increased anticoagulant respon ...... ients with advanced cirrhosis.
@en
Increased anticoagulant respon ...... ients with advanced cirrhosis.
@nl
prefLabel
Increased anticoagulant respon ...... ients with advanced cirrhosis.
@en
Increased anticoagulant respon ...... ients with advanced cirrhosis.
@nl
P2093
P2860
P1476
Increased anticoagulant respon ...... ients with advanced cirrhosis.
@en
P2093
K I Rodriguez-Castro
M T Sartori
P Zerbinati
V Rossetto
P2860
P304
P356
10.1111/J.1538-7836.2012.04824.X
P577
2012-09-01T00:00:00Z